FindTrial
Sign In

Clinical study for the integration of traditional Chinese and western medicine in the treatment of novel coronavirus pneumonia (COVID-19)

Clinical study for the integration of traditional Chinese and western medicine in the treatment of novel coronavirus pneumonia (COVID-19)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003009
Enrollment
Unknown
Registered
2020-02-13
Start date
2020-02-17
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Control group:Western medicine basic treatment
Experimental group:Western medicine basic treatment combined with traditional Chinese medicine

Sponsors

Shanghai Pulmonary Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Comply with the standards of diagnosis and classification of western medicine, and the standards of syndromes of traditional Chinese medicine. (2) Aged 18-80 years. (3) Those who voluntarily participated in this research and signed written informed consent.

Exclusion criteria

Exclusion criteria: (1) Impaired consciousness or mental illness cannot cooperate with treating the observer. (2) Those with severe organ dysfunction. (3) Pregnant women.

Design outcomes

Primary

MeasureTime frame
TCM symptoms efficacy;—

Secondary

MeasureTime frame
The number of days in hospital;Antipyretic time;Conversion rate of common and critical illness;Nucleic acid negative time;—

Countries

China

Contacts

Public ContactLixin Wang

Shanghai Pulmonary Hospital

wlx1126@hotmail.com+86 18917962300

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026